The general mechanisms that control the cell cycle in mammalian cells have been studied in depth and several proteins that are involved in the tight regulation of cell cycle progression have been identified. However, the analysis of which molecules participate in cell cycle exit of specific cell lineages is not exhaustive yet. Moreover, the strict relation between cell cycle exit and induction of differentiation has not been fully understood and seems to depend on the cell type. Several in vivo and in vitro studies have been performed in the last few years to address these issues in cells of the nervous system. In this review, we focus our attention on cyclin-cyclin-dependent kinase complexes, cyclin kinase inhibitors, genes of the retinoblastoma family, p53 and N-Myc, and we aim to summarize the latest evidence indicating their involvement in the control of the cell cycle and induction of differentiation in different cell types of the peripheral and central nervous systems. Studies on nervous system tumors and a possible contributory role in tumorigenesis of polyomavirus T antigen are reported to point out the critical contribution of some cell cycle regulators to normal neural and glial development.
Introduction
In order for an organism to develop, two kinds of processes are fundamental: cell division and cell differentiation. Both of these formative pathways must be carefully regulated and coordinated for normal growth to occur. The mechanisms that control cell growth and differentiation are now beginning to be understood. This is mainly because of the identification of molecules that orchestrate the cell cycle (Hunter, 1993; Sherr, 1994) .
In the recent years, great efforts have been dedicated to address the contribution of cell cycle exit to the acquisition of neural cell identity. The differentiation of multipotent neural progenitor cells into neurons or glial cells occurs over a protracted period and appears to be accompanied by a progressive restriction in the range of fates available to individual cells ( Figure 1 ) (Edlund and Jessell, 1999) . The fate of certain classes of neural cells appears to be restricted several divisions before cell cycle exit; however, for other cell types this restriction occurs much closer to the last mitosis, and for yet others only after they have reached the postmitotic stage (Edlund and Jessell, 1999) .
Immature cells in the developing spinal cord represent an example of restriction in developmental potential in the final progenitor cell cycle. The extrinsic signal Sonic hedgehog (Shh) directs the fate of several different neuronal types (Ericson et al., 1996) . Motor neuron progenitors require an early phase of Shh signaling; then, in their final cell cycle, they progress to a state of independence from Shh and at this point appear to commit to a motor neuron phenotype (Ericson et al., 1996; Tanabe et al., 1998) . Another example is provided by multipotent cells of the telencephalic ventricular area, which give rise to cells that exit the cell cycle and then undergo differentiation and migration (Rakic, 1974; Bayer et al., 1991) . However, the progenitor cells located within the anterior part of the subventricular area of the postnatal forebrain migrate to the olfactory bulb and concurrently undergo cell division, while expressing a neuronal phenotype (Luskin, 1993; Menezes and Luskin, 1994; Coskun and Luskin, 2001) . Also, certain neural crest-derived progenitor cells are indeed committed to a specific fate several cell divisions before their exit from the cell cycle (Edlund and Jessell, 1999) . In some cases, the specification of neural cell identity occurs after the last cell mitosis. A subset of sympathetic neurons, innervating sweat gland cells, undergo a developmental switch in their neural properties: they lose their initial noradrenergic transmitter phenotype and acquire cholinergic properties (Landis, 1990) .
Despite the above-described examples, cell cycle exit represents the fundamental step to trigger differentiation of cells and induction of a novel program of gene expression leading to the elaboration of a specialized phenotype (Hofbauer and Denhardt, 1991; Duronio and O'Farrell, 1994; Lassar et al., 1994; Boulikas, 1995; Edlund and Jessell, 1999) . Moreover, there is evidence demonstrating that several components of the cell cycle machinery play a major role also in neural cell specification and differentiation (Massague and Polyak, 1995; Bartek et al., 1997; Piette, 1997; ElShamy et al., 1998; Horsfield et al., 1998) .
Studies of myogenic differentiation provide a model for understanding how neural cell cycle exit coincides with the program of cell fate specification (Piette, 1997) . In this system, the activation of the MyoD family of bHLH proteins regulates muscle fate and differentiation. However, the execution of an overt myogenic differentiation program depends on cell cycle exit and reflects the inhibition of MyoD activity under conditions of cell proliferation and high cyclin-dependent kinase (CDK) activity (Lassar et al., 1994; Skapek et al., 1995; Walsh and Perlman, 1997; Zabludoff et al., 1998) . Thus, it appears that terminal mitosis and terminal differentiation are intimately coupled.
In this review, we will mainly focus on some mechanisms that regulate cell cycle exit and neural/glial differentiation.
Cell cycle regulation
The decision as to whether somatic cells become quiescent or resume active proliferation is dictated by extracellular and intracellular factors that act on the cell cycle machinery. This is composed of several factors that control cell cycle progression. The players in this scenario are holoenzymes composed of regulatory (cyclin) and catalytic CDK subunits. CDKs are initially activated through a series of steps, beginning with the association with a cyclin subunit followed by phosphorylation/dephosphorylation of specific amino acids.
The G 1 /S transition is the key step for cell cycle progression and is controlled by D-type cyclins/CDK4, D-type cyclins/CDK6, which act in mid-G 1 , and by cyclin E/CDK2, which operates in late G 1 (Figure 2 ) Stiegler et al., 1998; Harbour et al., 1999; Sherr and Roberts, 1999; Watanabe et al., 1999; Pucci et al., 2000) .
One key substrate of CDKs/cyclins is the nuclear tumor suppressor pRb (and its related proteins pRb2/ p130 and p107), which is phosphorylated on serine and threonine residues during G1 phase. pRb phosphorylation results in the liberation of E2F factors, whose
STEM CELLS

GLIAL PROGENITORS NEURAL PROGENITORS O-2A CELLS
NEURONS
ASTROCYTES
OLIGODENDROCYTES
Figure 1 A simplified model of neural stem cell (NSC) differentiation. NSCs can be committed toward either neural-or glialrestricted progenitors. Neuronal precursors differentiate into several types of mature neurons. Glial precursors can give rise directly to astrocytes or to O-2A progenitor cells, which in turn differentiate either in astrocytes or oligodendrocytes Figure 2 Cell cycle regulation and differentiation. G 1 /S cyclin/ CDK complexes and some of the proteins involved in their regulation are depicted in the picture. Ink4 CKI act on D-type cyclins/CDKs, while Cip/Kip proteins inhibit both cyclin D/CDKs and cyclin E/CDKs. Myc proteins positively regulate cell cycle progression by allowing the transcription of several components of the 'core cell cycle machinery'. On the contrary, p53 inhibits cell proliferation. This task is accomplished mainly through the induction of p21. Cyclin/CDK complexes phosphorylate and inhibit Rb proteins. Rb could promote cell differentiation by inactivating the E2F-dependent transcription of genes involved in cell proliferation and, at the same time, relieve Id2 inhibition of bHLH transcription factors that promote the expression of lineagespecific genes involved in differentiation Cell cycle regulation and neural differentiation U Galderisi et al activity is required for entry into S phase (Figure 2 ) Stiegler et al., 1998; Harbour et al., 1999; Sherr and Roberts, 1999; Watanabe et al., 1999; Pucci et al., 2000) . . The Ink4 proteins specifically interact with CDK4 and CDK6 and impair their interaction with D-type cyclins, whereas Cip/Kip molecules act on cyclin/CDK by forming a ternary complex (Figure 2 ) Stiegler et al., 1998; Harbour et al., 1999; Sherr and Roberts, 1999; Watanabe et al., 1999; Pucci et al., 2000) .
Cyclins, CDKs and differentiation
Terminally differentiated neural cells are arrested in the G 0 phase and some key positive regulators of the cell cycle are downexpressed. However, one of the most important cyclins in the late G 1 phase, cyclin D1, has been found to increase in some models of neural differentiation (Hayes et al., 1991; Okano et al., 1993; Yan and Ziff, 1995; van Grunsven et al., 1996) . In vivo analysis of cyclin D1 showed that its level increases during rat brain maturation and reduced cyclin D1 expression correlates with neural development delay induced by nutritional deprivation (Tamaru et al., 1993; Tamaru et al., 1994; Shambaugh et al., 1996) . On the other hand, disruption of the cyclin D1 gene in mice revealed neurological defects, such as abnormal limb reflex, similar to those observed by targeted disruption of genes important in neuronal development or function (Sicinski et al., 1995) .
The role of cyclin D1 has been studied in PC12 pheochromocytoma cells, which are one of the most common models utilized to study neuronal differentiation. Surprisingly, Yan and Ziff (1995) demonstrated that cyclin D1 was highly increased by inducers of differentiation, such as NGF and FGF, and not by inducers of proliferation (EGF and insulin). Although they observed an increase of cyclin D1/CDK2 and cyclin D1/CDK4 complexes in cells induced to differentiate, the associated kinase activity decreased (Yan and Ziff, 1995) . These results are in agreement with those reported by Xiong et al. (1997) . They investigated the role of cyclin D1 in bFGF-induced differentiation of a rat immortalized hippocampal cell line. After treatment with bFGF, there was a 10-fold increase of cyclin D1 protein that was localized primarily in the nucleus (Xiong et al., 1997) . However, overexpression of cyclin D1 per se did not promote neuronal differentiation. Furthermore, antisense inhibition of cyclin D1 expression did not produce differences in the kinetics or extent of cellular differentiation (Xiong et al., 1997) . All of the above researches do not explain why cyclin D1 increases during neuronal development. It has been suggested that cyclin D1 is required for growth arrest prior to commitment to differentiation (Yan and Ziff, 1995; Xiong et al., 1997) .
CDK5 is a CDK that is highly homologous to the other CDK proteins. However, its kinase activity is only detectable in postmitotic neurons of the central nervous system (Nikolic et al., 1996) . Unlike cyclin D1, which forms a complex with CDK5 both in vivo and in vitro without any known activity, a neuron-specific cyclin, p35, associates with and activates CDK5 (Xiong et al., 1992; Ishiguro et al., 1994; Lew et al., 1994; Tsai et al., 1994; Lee et al., 1996a; Nikolic et al., 1996) . Cyclin p35 is detected exclusively in postmitotic neurons of the central nervous system and its expression pattern parallels cortical neuron development (Nikolic et al., 1996) . In agreement with these observations, p35 knockout experiments in mice demonstrated that animals lacking p35 exhibit abnormal cortical lamination, probably because of abnormal neuronal migration (Chae et al., 1997) . In a rat hippocampal neuronal cell line, the overexpression of p35-induced cell differentiation and neurite outgrowth. These phenomena were blocked by coexpression of dominant-negative (dn) CDK5 protein, suggesting that p35 promotes neurite outgrowth through activation of CDK5 (Xiong et al., 1997) . Nevertheless, further experiments have shown that, in these cells, differentiation induced by FGF was not repressed by the inhibition of p35 expression obtained with antisense molecules (Xiong et al., 1997) .
Besides p35, another cyclin, called p39, has been shown to activate CDK5. Cyclin p39 has 57% aminoacid identity with p35 and is specifically detected in rat cerebrum and cerebellum (Tang et al., 1995) . It has been demonstrated that p39 ectopic expression in a rat neuronal cell line leads to neurite outgrowth and that differentiation induced by FGF is arrested by the inhibition of p39 expression obtained with antisense molecules. These studies suggest that p35 is sufficient but not required, and that p39 is both necessary and sufficient for neural differentiation in this experimental model (Xiong et al., 1997) .
Another intriguing study on the role of CDKs in neural development was carried out by Ferguson et al. (2000) . They infected cultures of mouse cortical neural progenitors with adenoviruses expressing dn CDK mutants to determine which cyclin/CDK complex plays a major role in neural cell cycle progression, and consequently must be inhibited to induce terminal mitosis and differentiation. Infection of neural cells with either dnCDK2 or dnCDK4/6 resulted in the arrest of cell cycle progression. In a second round of experiments, they infected Rb-deficient neural progenitors with either dnCDK2 or dnCDK4/6. The results demonstrated that both cyclin/CDK complexes are essential for cell cycle progression, and that cell growth regulation by CDK4/6 activity was entirely dependent on the Rb pathway. In contrast, it appeared that CDK2 functions only partially through an Rb-dependent pathway (Ferguson et al., 2000) .
Cyclin kinase inhibitors p27 Kip1
Differentiation is associated with a reduction in the overall amount of CDKs activity in G 1 . Consistent with this event, the accumulation of cyclin kinase inhibitors (CKIs) has been observed in many differentiated cell types in mice (Matsuoka et al., 1994; Parker et al., 1995) . In particular, several in vivo and in vitro studies have demonstrated that p27
Kip1 has a key role during neuronal differentiation.
In rat embryonic forebrains, the expression of p27 protein (detected by immunocytochemical staining) was weak in the ventricular zone of the cerebral cortex, a layer containing mainly proliferating neural progenitors. In agreement, in the cortical plate and preplate, which are composed mostly of postmitotic neurons, the expression of p27 was very high. Strong p27 expression was observed also in the neurons located in the basal telencephalon and the diencephalon (Lee et al., 1996a) . These data suggest that high p27 expression is characteristic of postmitotic neurons. High levels of p27 in postmitotic neurons correlated with p27 binding to and inactivation of CDK2. However, also cyclin p35/CDK5 complexes, which play a role in the control of cytoskeletal function in neurons, were present in these cells. The presence of an active cyclin p35/CDK5 complex raises the question of how CDKs could escape p27 inhibition. It has been suggested that p35/CDK5 could be refractory to p27 inhibition. This hypothesis is in accordance with the observation that no p27-bound CDK5 was detected by Western blotting or immunoprecipitation experiments performed on cell lysates obtained from rat postmitotic neurons (Lee et al., 1996a) .
In a multipotent embryonal carcinoma cell line induced to differentiate toward a neuronal phenotype by retinoic acid treatment, p27
Kip1 expression strictly correlated with the differentiation grade of neuronal cells. In this cell system, the growth arrest was preceded by accumulation of p27 and not of other CKIs (Baldassarre et al., 2000) . Moreover, evidence causally linking retinoic acid-dependent growth arrest and differentiation was provided by inhibition of retinoic acid-induced p27 upregulation by transfection of cell cultures with a plasmid expressing antisense p27 molecules. This treatment resulted in failure to block cell growth and to induce differentiation (Baldassarre et al., 2000) .
In the N2a-beta neuroblastoma cell line, the induction of neuronal differentiation by tri-iodothyronine (T3) treatment relies also upon p27 activity. T3-mediated growth arrest and differentiation were associated with augmented expression of p27 protein, which in turn led to a significant increase in p27/CDK2 complexes and marked inhibition of CDK2 kinase activity (Perez-Juste and Aranda, 1999) .
The most detailed information on the regulation and role of p27 protein in vertebrate neural cells emerged from studies on oligodendrocyte commitment and differentiation. A useful model for studying glial cell development is the O-2A bipotential progenitor cell, which can differentiate into either type 2 astrocytes or oligodendrocytes ( Figure 1 ) (Raff et al., 1983) . In O-2A cell cultures, differentiation may be induced either by withdrawing mitogens or by an intrinsic program, called 'internal clock'. This program is activated after a discrete number of divisions in the presence of mitogens, such as PDGF, and hydrophobic extracellular signals, such as the thyroid hormone (Durand et al., 1997) . The 'clock mechanism' postulates the existence of a molecular component (the counter) that is sensitive to the number of cell divisions. The counter must be linked to an 'effector', which triggers cell cycle arrest and differentiation (Durand et al., 1997) . The molecular nature of the counter has not been fully elucidated and it is not clear whether the 'internal clock' primarily controls the onset of differentiation, with the following arrest of the cell cycle or vice versa. However, it is evident that at some point the 'clock' must interact with regulators of cell cycle progression (Durand et al., 1997) . It was demonstrated that p27 protein progressively increases in O-2A cells in culture and reaches a plateau when cells stop dividing and differentiate. The time course of this increase is consistent with the possibility that p27 accumulation has a role both in the 'counter' and in the 'effector' activity (Durand et al., 1997) .
The role of p27 in cell cycle exit and differentiation of oligodendrocyte precursors was further investigated following the in vitro differentiation of O-2A cells obtained from p27-deficient mice. Under conditions that promote differentiation of wild-type cells, O-2A p27-deficient cells showed impaired growth arrest after mitogen starvation. However, a fraction of these cells was still able to undergo cell cycle exit and to perform a proper differentiation program . Impaired growth arrest correlated with continued progression of 0-2A cells into S phase. This observation suggests that p27 is a component of the mechanism, which regulates terminal mitosis of O-2A cells, but at the same time this protein has no role in the differentiation process .
The cell cycle exit, which is believed to precede the differentiation toward type 2 astrocytes of O-2A precursor cells, appears also to be regulated by p27 protein. In fact, in CG-4 cells (a clonal glial cell line with characteristics of O-2A cells) the differentiation toward mature astrocytes is accompanied by a progressive increase in p27 expression, which in turn blocks the activity of G 1 CDKs .
The p27 protein is also involved in the control of cerebellar granule cell precursors (GCPs) proliferation. p27 expression was analysed in the developing cerebellum of mouse embryos (Miyazawa et al., 2000) . p27 was expressed at higher levels in the GCPs of the deeper areas of external germinal layers than in cells of the middle zone. This finding suggests that p27 gradually accumulates in GCPs as they proliferate, and not after cell cycle exit. Furthermore, in cultured GCPs it was demonstrated that there was an inverse correlation between p27 expression and bromo-deoxyuridine incorporation (a hallmark of cell cycle progression). All these data suggest that p27 could be part of the intracellular mechanism regulating the cell cycle exit that precedes cell differentiation, as observed in oligodendrocyte precursors (Miyazawa et al., 2000) .
Evidence showing that p21 Cip1 participates in the regulation of neural differentiation has been provided by in vitro studies on PC12 pheochromocytoma cells. It was demonstrated that the in vitro differentiation of PC12 cells induced by NGF is accompanied by a huge increase in p21 protein levels (Erhardt and Pittman, 1998) . In agreement with this observation, it was demonstrated that the ectopic expression of p21 in this cell line resulted in growth arrest associated with an increase in cyclin D1 and cyclin E levels along with a decrease in cyclin A, cyclin B, Cdc2 and CDK4 levels. The cell cycle exit induced by p21 ectopic expression triggered the differentiation of PC12 cells toward a mature neuronal phenotype. Overall, the cell cycle changes and the induction of differentiation observed following p21 overexpression mimicked the changes in PC12 cell biology induced by NGF treatment (Erhardt and Pittman, 1998) . This observation further lends credit to the hypothesis that p21 plays a major role in neural precursor cell cycle exit and differentiation.
Basic helix-loop-helix (bHLH) transcription factors participate at different stages of neural stem cell (NSC) differentiation. It has been demonstrated that astroglial differentiation of NSCs requires the expression of the HES proteins, which are members of the bHLH family. The inhibition of their expression by the antisense technique results in the triggering of neuronal differentiation. The block of HES activity affects two different stages of neuronal differentiation. The first is the selection of neuronal versus glial fate and the second is the selection of a specific neuronal phenotype (Kabos et al., 2002) . The inhibition of HES expression and the subsequent neuronal differentiation are associated with a huge increase in p21 protein levels and p21 was the only CKI, which showed a significant change in its expression during this process. These results suggest that bHLH regulation of NSC differentiation is interconnected with a p21 Cip1 -dependent pathway (Kabos et al., 2002) .
A study on the in vitro maturation of O-2A cells to the oligodendrocyte phenotype demonstrated that p21 and p27 are both required for proper differentiation of these precursor cells. However, these two CKIs control different aspects of the differentiation process. O-2A cells isolated from either p21-or p27-deficient mice were cultured in differentiation medium for several days. It was observed that p21-and p27-deficient cells failed to differentiate with wild-type kinetics and required longer times (Zezula et al., 2001) . It was also demonstrated, by bromo-deoxyuridine incorporation, that while p21-deficient cells exited the cell cycle within the first day in culture as the wild-type cells, p27-deficient cells continued to proliferate even after 5 days in culture.
These data suggested that these two CKI proteins play nonredundant roles in oligodendrocyte maturation: p27 appears to be required for cell cycle arrest and p21 could have a role in differentiation, independent by its ability to control cell cycle progression (Zezula et al., 2001) .
Among the Ink4 family members, only p18
INK4c and p19
INK4d are expressed in fetal mouse development, and typical expression patterns have been observed in the central nervous system from embryonic E11.5 developmental day onward (Zindy et al., 1997a, b) . In particular, during the development of the neocortex, neuronal precursors exit the cell cycle, migrate to their final position in the cortex and differentiate (Caviness et al., 1995) . In these cells, p18 expression is turned off as they exit from the cell cycle and is replaced by p19, whose expression continues in postmitotic neurons and is maintained into adulthood (Zindy et al., 1997a) . The persistence of p19 expression may therefore keep neurons in a postmitotic state, thereby playing a role in the final phase of cell differentiation.
The regulation of p19 expression could decide whether neuronal differentiation starts before or after cell cycle exit (Coskun and Luskin, 2001 ). As reported above, neuronal precursors located in the posterior regions of the telencephalic ventricular areas differentiate after cell cycle exit. In contrast, the precursors located within the anterior part of the subventricular area start differentiation while they are still cycling (Rakic, 1974; Bayer et al., 1991; Luskin, 1993; Menezes and Luskin, 1994; Coskun and Luskin, 2001 ).
The analysis of p19 expression pattern in developing mouse brains has demonstrated that in the telencephalic ventricular zone the increase in p19 expression, observed at the time of cell cycle exit, persists also in postmitotic neurons. On the contrary, neuronal progenitor cells located in the anterior part of the subventricular zone have exhibited a different developmental pattern of p19 expression. It has been suggested that these cells undergo multiple rounds of cell division by repetitively downregulating their p19 expression (Coskun and Luskin, 2001 ). These data indicate that in the developing cerebral cortex, neuronal precursor cells leave the cell cycle, differentiate and remain forever postmitotic. In contrast, neurons generated in the anterior part of the subventricular area may successively downregulate their p19 expression and re-enter the cell cycle before becoming permanently postmitotic neurons (Coskun and Luskin, 2001 ).
Proteins associated with the adenovirus 5 E1A oncoprotein and neural differentiation DNA tumor viruses have been shown to be effective tools in the identification of protein factors that regulate fundamental cellular processes such as transcription, RNA processing and DNA replication. The transforming gene products of these viruses, such as the E1A oncoprotein of adenovirus have also helped to identify cellular factors involved in neoplastic transformation as well as in physiological activities. The importance of the retinoblastoma (RB) family (pRb/p105, p107 and pRb2/ p130) in the inhibition of proliferation and their direct or indirect role in the cell cycle are evidenced by the necessity of a number of oncogenic DNA viruses to encode functional oncoproteins including E1A, T antigen and E7, which can effectively bind and sequester RB family members, in order to elicit a transformed phenotype in infected cells. The role of RB family in cell cycle regulation has been strictly linked to promoting cell differentiation.
Rb-, p53-and Myc-pathways are among the main molecular mechanisms that contribute to regulating the functions of cell cycle machinery, and are also intimately interconnected with differentiation pathways. Some examples on these topics are reported in the following paragraphs.
RB family
The RB family genes, RB, RB2/p130 and p107, play a major role in controlling the cell cycle. This function is mainly accomplished by the differential binding of RB family proteins to the members of the E2F family of nuclear factors, which in turn regulate the transcription of several genes involved in DNA synthesis and cell cycle progression (Figure 2 ). RB family proteins are the substrate of different cyclin-CDK complexes and hence undergo cyclic phosphorylation and dephosphorylation: in the hypophosphorylated active status, they bind E2F family members and inhibit their function, while they are inactive when hyperphosphorylated (Paggi et al., 1996; Kasten and Giordano, 1998; Stiegler et al., 1998) . Although some data indicate that pRb, pRb2/p130 and p107 are able to compensate each other, their specific binding properties suggest that each RB family protein plays a distinct role in cell cycle regulation, depending on cell maturation state and type (Lee et al., 1992; Claudio et al., 1994; Hurford et al., 1997; LeCouter et al., 1998a, b) .
The RB gene family members are also involved in the onset of differentiation in a wide variety of cell types (Garriga et al., 1998; Stiegler et al., 1998; Lipinski and Jacks, 1999) . Several data indicate that pRb and pRb2/ p130 play a crucial role in neurogenesis. In mouse embryos that lack both copies of the RB gene, dividing neural precursor cells are found outside of the normal neurogenic regions in both the central and peripheral nervous systems. Many of the ectopically dividing cells die by apoptosis; moreover, the expression of several neural differentiation markers is greatly reduced (Clarke et al., 1992; Jacks et al., 1992; Lee et al., 1992 Lee et al., , 1994 . Mice lacking either pRb2/p130 or p107 in a mixed 129/ Sv : C57Bl/6J genetic background exhibited no overt phenotype; furthermore, they were viable and fertile (Lee et al., 1994; Cobrinik et al., 1996; Herrera et al., 1996 ; Hurford et al., 1997). Embryos lacking both pRb2/p130 and p107 died in utero 2 days earlier than Rb-deficient embryos and exhibited apoptosis in the liver and central nervous system, suggesting some redundancy in function (Cobrinik et al., 1996; Lee et al., 1996b) . However, in a Balb/CJ genetic background the knockdown of pRb2/p130 produced embryonic lethality associated with increased cellular proliferation and apoptosis in the neural tube (LeCouter et al., 1998b) . In detail, histological analysis revealed varying degrees of disorganization in neural structures and a poorly formed notochord. The differentiation of motoneurons in the ventral horn was impaired and there was a decreased number of sensory neurons within a poorly demarcated dorsal root ganglia. Moreover, the neural epithelium in the neural tube failed to produce a basement membrane (LeCouter et al., 1998b) .
Several in vitro studies confirmed that the RB family plays a major role in neural cell differentiation. P19 embryonal carcinoma multipotent cells can be induced to differentiate in vitro into neurons and astrocytes when treated with retinoic acid. During this neuroectodermal differentiation, the level of RB family proteins rises dramatically from barely detectable levels in the undifferentiated cells (Slack et al., 1995) . The functional inhibition of RB family members by ectopic expression of a mutated adenovirus E1A protein in P19 cultured cells caused a huge increase in apoptosis of differentiating neurons and astrocytes (Slack et al., 1995) .
The role of pRb in neurogenesis was further investigated by introducing a neuronal marker gene into mice lacking a functional RB gene. The marker transgene consisted of the neuron-specific promoter alpha-tubulin driving a lacZ reporter gene that was induced as progenitor cells were committed to a neuronal fate (Slack et al., 1998; Gloster et al., 1994 Gloster et al., , 1999 . These studies demonstrated that in pRb-deficient mice, several aberrations in the developing nervous system occur. Moreover, the timing of marker gene expression suggested that pRb becomes essential immediately following commitment to a neuronal fate and that in its absence a huge cell death phenomenon occurs (Slack et al., 1998) .
Other studies appeared to confute that pRb plays a major role in neurogenesis. In fact, primary neuron cell cultures, obtained from mice lacking the RB gene, survived and differentiated as the wild-type counterpart (Lee et al., 1994; Slack et al., 1998; Callaghan et al., 1999) . However, it was demonstrated that cortical progenitor cells from RB-null mice exhibited delayed terminal mitosis and a compensatory increased p107 expression. In spite of this gene compensation, a deregulation of E2F1 and E2F3 activity was observed in Rb-deficient cells (Callaghan et al., 1999) .
Our research group (also in collaboration with Paggi and colleagues) has performed several studies on the role of RB family members in differentiation. We determined the expression and phosphorylation status of RB family gene products during DMSO-induced differentiation of N1E-115 murine neuroblastoma cells (Raschella et al., 1998) . In this system, pRb2/p130 was strongly upregulated during mid-late differentiation stages, while, on the Cell cycle regulation and neural differentiation U Galderisi et al contrary, pRb and p107 were found to be markedly decreased at the late stages. Differentiating N1E-115 cells also showed a progressive decrease in B-myb levels, a proliferation-related protein whose constitutive expression inhibits neuronal differentiation. Transfection of each of the RB family genes in these cells was able, at different degrees, to induce neuronal differentiation, inhibit [
3 H] thymidine incorporation and downregulate the activity of the B-myb promoter (Raschella et al., 1998) . Since neuroblastoma cell lines are heterogeneous and could behave in different way following ectopic gene regulation or drug treatment, we analysed the role of the RB family in neural differentiation by studying also the human neuroblastoma cell line LAN-5 (Raschella et al., 1997) . We demonstrated that pRb2/ p130 expression levels increase during differentiation of LAN-5 neuroblastoma cells. On the other hand, both pRb and p107 decreased and underwent progressive dephosphorylation at late differentiation times (Raschella et al., 1997) . The expression of B-myb and c-myb, two targets of the RB family proteins, was downregulated in association with the increase of pRb2/ p130, which was detected as the major component of the complexes with E2F on the E2F-binding site of the Bmyb promoter in differentiated cells. Interestingly, E2F4, a preferential partner of p107 and pRb2/p130, was upregulated and underwent changes in cellular localization during differentiation (Raschella et al., 1997) .
Other studies have been aimed at understanding the role of RB2/p130 in commitment and differentiation of neuroblastoma neural crest stem cells. Neuroblastoma cells are a convenient model for studies on neural crest progenitor cells . These tumor cells show various phenotypes that represent different neural populations: the neuroblastic (N) phenotype, the Schwann/glial/melanocytic-like (S) phenotype and the intermediate (I) phenotype, which has been demonstrated to represent a multipotent embryonic precursor cell of the peripheral nervous system (Ross et al., 1995) .
We demonstrated that RB2/p130 ectopic expression induces morphological and molecular modifications, promoting differentiation of I phenotype SK-N-BE(2)-C neuroblastoma cells toward a neuroblastic (N) rather than a Schwann/glial/melanocytic (S) phenotype. These modifications are stable as they persist even after treatment with an S phenotype inducer. RB2/p130 ectopic expression also induces a more differentiated phenotype in N-type SH-SY-5Y cells. Further, this function appears to be independent from cell cycle withdrawal. The data reported suggest that pRb2/p130 is able to induce neuronal lineage specification and differentiation in neural crest stem and committed neuroblastoma cells, respectively. Thus, pRb2/p130 seems to be required throughout the full neural maturation process .
The role of pRb and pRb2/p130 in glial genesis is less characterized. These findings are hindered also by the fact that both RB-and RB2/p130-deficient mouse embryos die early in the development, before the complete genesis of glial cells (Lee et al., 1994; LeCouter et al., 1998b; Callaghan et al., 1999) .
We contributed to elucidating the role of pRb2/p130 in astrocyte development. For this purpose, we ectopically expressed the pRb2/p130 protein in astrocytoma and normal astrocyte cultures by adenoviral-mediated gene transfer. In astrocytoma cells, RB2/p130 ectopic expression resulted in a significant reduction of cell growth and in an increased G 0 /G 1 cell population. We did not observe any induction of programmed cell death as determined by TUNEL reaction. Interestingly, RB2/ p130 ectopic expression induced astrocyte differentiation. Astrocyte cell cycle arrest and differentiation seemed to proceed through a pathway that was independent from p53 .
While a major role for pRb and pRb2/p130 in neural differentiation has been demonstrated, how their function is accomplished remains to be determined. At least two different mechanisms could trigger RB familymediated differentiation. The first relies upon transcriptional repression of E2F-responsive promoters; the other one could be ascribed to the activation of bHLH proteins.
The E2F transcription factor family is composed of six members, from E2F1 to E2F6. These factors heterodimerize with either DP-1 or DP-2 proteins and bind specific DNA consensus sequences located in promoters of several genes involved in cell cycle progression (Sidle et al., 1996; Dyson, 1998) . Most of the E2F factors (except E2F6) bind to the RB family proteins. However, these interactions are restricted; in fact, pRb binds preferentially to E2F1, E2F2 and E2F3, while p107 binds to E2F4 and pRb2/p130 to E2F4 and E2F5. Binding of the RB family proteins to E2F activation domain blocks transactivation by E2Fs (Sidle et al., 1996; Dyson, 1998; Kasten and Giordano, 1998; Stiegler et al., 1998) .
In several systems, terminal differentiation is accompanied by exit from the cell cycle, dephosphorylation of RB family members along with loss of free E2F complexes (not associated with RB proteins). As differentiation proceeds, there is an increase in pRb-E2F and pRB2/p130-E2F complexes (Sidle et al., 1996; Dyson, 1998; Stiegler et al., 1998) . A strong increase in pRB2/p130 levels and a reduction of p107 was observed during retinoic acid-induced differentiation of the multipotent carcinoma cell line P19 into mature neurons. These changes were reflected by a quantitative shift of E2F-site binding complexes containing p107 to complexes containing pRb2/p130 (Corbeil et al., 1995; Sidle et al., 1996) . It has been suggested that while E2F1, E2F2 and E2F3 act mainly as inducers of cell cycle progression, E2F4 and E2F5 are important during the differentiation process (Sidle et al., 1996; Dyson, 1998; Stiegler et al., 1998) . This hypothesis agrees partially with the E2F expression pattern during mouse neural development. The expression of E2F1, E2F2 and E2F5 has been detected in proliferating neuronal precursors of developing mouse brain; as the neurons differentiated, the expression of these factors greatly decreased (Dagnino et al., 1997) . Other research performed on PC12 pheochromocytoma cells has demonstrated that E2F4 plays a role in neuronal differentiation. Following NGF-induced neuronal differentiation, there was a huge increase of E2F4 expression level along with an increased amount of pRb2/p130-E2F4 complexes (Persengiev et al., 1999) .
The bHLH family of transcription factors regulates gene expression, orchestrating cell cycle control, cell lineage commitment and cell differentiation. The HLH domain primarily mediates homo-or heterodimerizations, which are essential for DNA binding and transcriptional regulation (Norton, 2000) . Many positively acting bHLH proteins are expressed in the developing central nervous system and play a crucial role in neural differentiation (Lee, 1997) . Among these, the bHLH proteins NeuroDs are required for the proper differentiation of neurons present in the cerebellum and in the hippocampus of mouse embryos; the Math proteins are essential for the genesis of cerebellar granule neurons in mice (Ben-Arie et al., 1997; Miyata et al., 1999; Schwab et al., 2000) . Toma et al. (2000) demonstrated that bHLH proteins collaborate with pRb to regulate cortical neurogenesis. They inhibited all bHLH transcriptional activity by overexpressing Id2, a member of the Id family, in primary cultures of cortical progenitors and neurons. The members of the Id family (Id1, Id2, Id3 and Id4) do not possess a basic DNA-binding domain and function as dn regulators of bHLH proteins (Benezra et al., 1990; Christy et al., 1991; Sun et al., 1991) . Furthermore, Id2 function has been coupled to cell cycle machinery through a direct interaction with pRb, pRb2/130 and p107 (Figure 2) (Iavarone et al., 1994; Lasorella et al., 1996) . The ectopic expression of Id2 by adenovirus infection of cortical progenitor cultures arrested neuronal differentiation and triggered apoptosis. These phenomena were inhibited by coexpression of a constitutively activated pRb mutant, which restored the proper differentiation process (Toma et al., 2000) . How does pRb rescue neuronal differentiation in cells over expressing Id2 ? Toma et al. proposed that pRb, by binding to Id2, inhibits its ability to bind to and inhibit positively acting bHLH proteins.
RB family and viral oncoproteins in nervous system tumors
The importance of RB family in neural and glial cell development and differentiation is further underscored by the observation that alterations in the Rb pathways are found in several types of tumors, occurring both in the peripheral and the central nervous system.
Mutations in the genes of Rb family members have been described in human astrocytomas, glioblastomas and gliosarcomas (Ueki et al., 1996; Louis, 1997; Nozaki et al., 1999; Rathore et al., 1999; Puduvalli et al., 2000; Reis et al., 2000; Wechsler-Reya and Scott, 2001) . The loss of Rb activity determines cell growth deregulation along with improper cell differentiation. In the last few years, it has been observed that inhibition of Rb pathways by viral oncoproteins could contribute to neuroblastoma and glioblastoma development. In studies on 18 human neuroblastomas and five normal human adrenal glands, BK polyomavirus DNA was detected in all tumor samples but in none of the normal adrenal glands (Flaegstad et al., 1999) . The expression of BK virus T antigen could contribute to tumor development, inhibiting the activity of tumor-suppressor genes, such as RB family members and p53. Another study demonstrated the presence of human JC polyomavirus T antigen in glioblastoma samples Del Valle et al., 2002) , further suggesting that neurotropic viruses could play a role in neural cell tumorigenesis and that the RB family is crucial for control of normal neuronal and glial development. In particular, we demonstrated that induction of pRb2/ p130 in a glioblastoma cell line expressing the polyomavirus T antigen was able to overcome JCV T-Agmediated cellular aberrant proliferation (Howard et al., 1998) . The same results were obtained with in vivo injection of tumor cells into nude mice: the induction of pRb2/p130 expression brought about a 3.2-fold reduction in final tumor mass (Howard et al., 1998) . pRb2/ p130 counteracts the neoplastic transformation induced by the JCV T antigen through the inhibition of cyclin Aand cyclin E-associated kinase activity and, by doing so, induces p27
Kip (Howard et al., 2000) .
p53 pathway
The tumor-suppressor p53 gene is involved in cell cycle regulation and differentiation in several biological systems. p53 is a transcription factor that can transactivate genes of importance both for apoptosis (such as BAX) and for G 1 arrest (such as p21) (Giaccia and Kastan, 1998) . The molecular mechanisms for p53-mediated differentiation are not clear but appear to rely on the induction of p21 or on cell cycle arrest mediated by the hypophosphorylation of pRb (Ehinger et al., 1997; Giaccia and Kastan, 1998; Chylicki et al., 2000a, b) . Whatever the molecular pathway for p53-induced differentiation, several studies have reported an involvement of p53 in neural cell differentiation. Eizenberg et al. (1996) analysed the expression and subcellular localization of p53 in cultures of hippocampal neurons. Soon after in vitro plating, the p53 protein was detected mainly in cell nuclei and was barely seen in the cytoplasms. The maturation process of these cells was associated with a gradual reduction of p53 expression in the nucleus. Finally, the fully differentiated neurons showed p53 expression localized only into the cytoplasm (Eizenberg et al., 1996) . However, the neurons utilized in these experiments were already committed to differentiation. Thus, the authors performed the same study on the PC12 cell line, which is composed of uncommitted neuronal progenitors. Immunostaining experiments showed that p53 was barely detected in the nuclei of proliferating PC12 cells. Then,
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Cell cycle regulation and neural differentiation U Galderisi et al when cells were induced to differentiate by NGF treatment, high levels of p53 were found in the nuclei. Finally, when cells were fully differentiated p53 was detected only in the cytoplasms. All these studies suggest that at early stage of neuronal differentiation, p53 accumulates in the nucleus, where it may activate genes involved in cell differentiation. Once cells become committed toward maturation, p53 is probably no longer needed in the nucleus (Eizenberg et al., 1996) .
The involvement of p53 in neural differentiation has been further demonstrated by the treatment of PC12 cell cultures with retroviruses expressing a dn form of p53 (dn-p53). These experiments showed a substantial reduction in the percentage of differentiating neurons in cultures expressing the dn form of p53 compared to controls (Eizenberg et al., 1996) . p53 contributes also to oligodendrocyte differentiation. Cultures of O-2A cells, obtained from the optic nerve of P7 rats and infected with retroviruses encoding a dn form of p53, were induced to differentiate either by mitogen withdrawal or by treatment with hydrophobic extracellular signals (thyroid hormone). The expression of dn-p53 completely inhibited both cell cycle withdrawal and differentiation induced by thyroid hormone. This finding suggests that p53 is part of the effector component utilized by the 'internal clock mechanism' of O-2A cells to induce cell differentiation. In contrast, dnp53 had no effect on oligodendrocyte differentiation following mitogen starvation. As a consequence, differentiation obtained by mitogen deprivation is believed to proceed through a p53-independent pathway (Tokumoto et al., 2001) .
N-Myc in neurogenesis
The Myc family (c-, N-, L-and S-Myc) of bHLH-Zip transcription factors have been implicated in the control of cell proliferation and differentiation (Queva et al., 1998; Luscher and Larsson, 1999) . However, while cMyc is fairly ubiquitous, the other members of the family are expressed only in specific tissues and organs. In particular, N-Myc has a restricted spatio-temporal expression. It is expressed mainly in the central and peripheral nervous systems, kidney, lung and spleen. Moreover, its expression is high during early stages of development and decreases in adult organisms (Queva et al., 1998) .
N-Myc-deficient mice have shown severe abnormalities in organs where the gene is mainly expressed (Stanton et al., 1992; Sawai et al., 1993) . For example, they showed great reduction in the number of mature neurons of the dorsal root ganglia and sympathetic ganglia, indicating the importance of N-Myc expression in the production of neurons, especially those derived from the neural crest (Stanton et al., 1992; Sawai et al., 1993) .
Analysis of N-Myc expression in mouse embryos has indicated that this protein is expressed rather uniformly in the migrating crest cells. However, during the progression of embryo development, its expression becomes restricted to cells undergoing neuronal differentiation, suggesting that N-Myc expression has a determining effect on the neuronal/non-neuronal choice of neural crest cells (Wakamatsu et al., 1997) .
Avian embryos represent a useful model to study neural crest development; for this reason, the expression of N-Myc protein in the trunk neural crest cells has been examined in chicken and quail embryos (Wakamatsu et al., 1997) . N-Myc protein was detected in the nuclei of all neural crest cells before and after their migration from the dorsal margins of the neural tube. It was noteworthy that, as neuronal maturation proceeds, NMyc localization switches from nucleus to cytoplasm (Wakamatsu et al., 1997) . Although the significance of cytoplasmic N-Myc protein in gene regulation has not been fully understood, it may be hypothesized, as it was postulated for p53 protein, that at early stages of neuronal differentiation, N-Myc accumulates in the nucleus, where it could be involved in the regulation of cell proliferation and differentiation. Once cells become committed toward the neuronal phenotype, N-Myc is probably no longer needed in the nucleus.
To analyse the role played by N-Myc in the development of neural crest cells, we inhibited its expression in three different neuroblastoma cell phenotypes by the antisense technique (Galderisi et al., 1999) . The downregulation of N-Myc protein in neuroblastoma stem cells with an (I) phenotype resulted in the inhibition of cell proliferation, while no induction toward either Schwann-glial or neuronal phenotype was observed. On the contrary, the inhibition of N-myc activity in cells committed toward (N)-or (S)-phenotypes resulted in the induction of differentiation along with a decrease in the proliferation rate (Galderisi et al., 1999) . These data suggest that N-Myc expression could regulate the proliferation of neural multipotent crest cells. Moreover, once cells are committed to a specific phenotype, N-Myc expression should decrease to allow a complete differentiation to be reached.
Other studies support this hypothesis. In cultures of neuronal precursor cells derived from null N-Myc mouse embryos, a severe reduction of cell proliferation with a huge diminution of S phase and mitotic cells was observed. Moreover, the differentiation process was impressively increased (Knoepfler et al., 2002) .
Conclusions
It is clear that interactions among extrinsic and intrinsic signals determine cell commitment and differentiation. Thus, for a given cell, the decision about its fate arises from a unique and specific combination of these signals. Nevertheless, it is mandatory to rely upon components of cell cycle machinery to execute the order. For these reasons, these molecules do not simply regulate cell division; rather they are part of the 'committee' that decides cell fate.
Another point should be stressed. By studying proteins involved in cell cycle machinery, one could argue that their job is almost the same in all biological systems: they have to regulate (positively or negatively) cell cycle progression. Indeed, an in-depth look at the 'cell cycle world' allows us to understand that, for example, even if the CKIs work everywhere to block cell cycle progression, each of them could preferentially act in a specific system rather than in another. As reported in this review, among the CKIs, p27 appears to be a keystone protein in neurogenesis. Moreover, the tight regulation of cell proliferation and cell differentiation needed for the correct development of an organism is afforded by the complex interplay between the molecules involved in cell cycle control and the bHLH family of transcription factors responsible for the expression of lineage-specific genes.
